Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

HHS sued over RFK’s $11B cuts to infectious disease control
The Department of Health and Human Services is refusing to allocate funds meant to support state and local healthcare initiatives, as the money stemmed from now-defunct COVID-19 control efforts. A coalition of municipalities is suing to lift the block.
Robotic mitral valve repair linked to benefits for elderly patients
Robotic and traditional mitral valve repair surgeries are mostly associated with similar outcomes when treating elderly patients. In some ways, however, robotic procedures may be preferred.
Vendor payments not responsible for rising popularity of LAAO procedures
Consulting fees and other vendor payments do not appear to be directly influencing U.S. physicians to implant more Watchman devices. Researcher Alexander Kolomaya, MD, discussed his team's findings on this topic.
AI predicts pediatric cancer recurrence with impressive accuracy
Researchers have developed a deep learning model that can spot longitudinal changes in patients' brain imaging that could be indicative of cancer recurrence.
AI helps cardiologists terminate AFib for good with ablation
Advanced AI can provide real-time feedback to cardiologists, helping them deliver high-quality care.

Diabetes, hypertension more common among breast cancer survivors

Women who received left-sided radiation or endocrine therapy appear to be impacted the most by this trend.

Supreme Court allows CMS vaccine mandate for healthcare workers, blocks rule for large businesses

The American Hospital Association praised the court's decision to allow the mandate on federally funded healthcare facilities and said it will work to balance potential workforce shortages.

FDA announces a new recall for extended-release metformin due to contamination

The FDA first announced the detection of high levels of NDMA, a contaminant associated with cancer, in extended-release metformin products back in May 2020.